Partha P. Majumder, Saurabh Ghosh
J Clin Invest.
2005;
115(6):1419–1424
doi:10.1172/JCI24757
This article Copyright © 2005, The American Society for Clinical Investigation
Abstract
|
Full text
|
PDF
|
Supplemental material
R
ecent advances in statistical methods and genomic technologies have ushered in a new era in mapping clinically important quantitative traits. However, many refinements and novel statistical approaches are required to enable greater successes in this mapping. The possible impact of recent findings pertaining to the structure of the human genome on efforts to map quantitative traits is yet unclear.
